vancomycin has been researched along with Ebola Hemorrhagic Fever in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Armocida, D; Boeris, D; Cofano, F; Garbossa, D; Guerrini, F; Tartara, F; Viganò, M; Zoia, C | 1 |
1 other study(ies) available for vancomycin and Ebola Hemorrhagic Fever
| Article | Year |
|---|---|
The Use of Intraventricular Instillation of Vancomycin to Prevent External Ventricular Drainage Related Infection: A Clinical Prospective Study.
Topics: Anti-Bacterial Agents; Case-Control Studies; Cefazolin; Drainage; Hemorrhagic Fever, Ebola; Humans; Prospective Studies; Retrospective Studies; Vancomycin | 2022 |